These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35114406)

  • 1. Anti-aquaporin-4 immunoglobulin G colorimetric detection by silver nanoparticles.
    Higa AM; Moraes AS; Shimizu FM; Bueno RG; Peroni LA; Strixino FT; Sousa NAC; Deffune E; Bovolato ALC; Oliveira ON; Brum DG; Leite FL
    Nanomedicine; 2022 Apr; 41():102531. PubMed ID: 35114406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.
    de Souza Moraes A; Brum DG; Ierich JCM; Higa AM; Assis ASJ; Miyazaki CM; Shimizu FM; Peroni LA; Machini MT; Barreira AA; Ferreira M; Oliveira ON; Leite FL
    Sci Rep; 2019 Nov; 9(1):16136. PubMed ID: 31695085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
    Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
    Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
    J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different alteration patterns of sub-macular choroidal thicknesses in aquaporin-4 immunoglobulin G antibodies sero-positive neuromyelitis optica spectrum diseases and isolated optic neuritis.
    Peng C; Li L; Yang M; Teng D; Wang J; Lai M; Qian H; Li H; Zhou H; Xu Q; Wei S
    Acta Ophthalmol; 2020 Dec; 98(8):808-815. PubMed ID: 32657009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
    Hamid SH; Elsone L; Mutch K; Solomon T; Jacob A
    Mult Scler; 2017 Feb; 23(2):228-233. PubMed ID: 27553618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
    You Y; Zhu L; Zhang T; Shen T; Fontes A; Yiannikas C; Parratt J; Barton J; Schulz A; Gupta V; Barnett MH; Fraser CL; Gillies M; Graham SL; Klistorner A
    Ophthalmology; 2019 Jun; 126(6):801-810. PubMed ID: 30711604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder.
    Fu Y; Bi J; Yan Y; Sun X; Li K; Kim SY; Han SM; Zhou L; Li R; Huang Q; Wang N; Lin A; Kim HJ; Qiu W
    JAMA Neurol; 2023 Oct; 80(10):1105-1112. PubMed ID: 37669037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder.
    Tradtrantip L; Yeaman MR; Verkman AS
    Sci Rep; 2021 Nov; 11(1):21962. PubMed ID: 34753987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
    J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay.
    Liu C; Zhu M; Wang Y
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31009006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AQP4-DARPin1: A Chimeric Antigen Based on Scaffold Protein DARPin for Efficient Detection of AQP4-IgG in NMOSD.
    Wang X; Ma S; Bai Y; Wu X; Ji F; Jia L
    Biochemistry; 2024 Apr; 63(7):855-864. PubMed ID: 38498694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
    Marignier R; Pittock SJ; Paul F; Kim HJ; Bennett JL; Weinshenker BG; Wingerchuk DM; Green AJ; Fujihara K; Cutter G; Aktas O; Hartung HP; Drappa J; Ratchford JN; She D; Smith M; Rees W; Cimbora D; Katz E; Cree BAC;
    Mult Scler Relat Disord; 2022 Jan; 57():103356. PubMed ID: 35158465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
    Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ
    J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tuller F; Holzer H; Schanda K; Aboulenein-Djamshidian F; Höftberger R; Khalil M; Seifert-Held T; Leutmezer F; Berger T; Reindl M
    J Neuroinflammation; 2016 Jul; 13(1):176. PubMed ID: 27371173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.